Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Published Date: 17 Feb 2023

Antibiotic use linked to SJ syndrome and toxic epidermal necrosis, sulfonamides are worst culprits in new study...

Read Full News

Latest News

Make the Diagnosis: This Cyst Is Asymptomatic. Is It a Problem?

A 67-year-old man visited the doctor for a cyst-like lesion that developed on his face 3 months prior.

Targeted Oral Drug Plus UV Therapy May Help in Extensive Vitiligo

Positive signs in phase II test

Novel Drug Eases Disease Activity in Dermatomyositis

Dazukibart targets specific molecular pathology of chronic systemic autoimmune disease

Biomarker May Flag Humira Responders in Hidradenitis Suppurativa

Patients' C-reactive protein levels also reflect significantly higher BMI and disease severity

What Botox Teaches Us About Serendipity in Clinical Encounters

Don't forget the power of a strong doctor-patient relationship

Make the Diagnosis: Are Her Nail Symptoms Part of a Larger Picture?

A 62-year-old woman visited her doctor about thick, crumbling, discolored toenails that developed over many months. Can you diagnose the patient?

Todays Updates

FDA Accepts NDA for Low-Sodium Oxybate TRN-257 in Narcolepsy and Idiopathic Hypersomnia Isabella Ciccone, MPH

TRN-257, a treatment in development for adults with narcolepsy and idiopathic hypersomnia, is designed to reduce daily sodium exposure relative to existing higher-sodium therapies.

NeuroVoices: Richard Rammo, MD, on How Thalamic Neuromodulation is Evolving for Drug Resistant Epilepsy Marco Meglio, Richard Rammo, MD

The neurosurgeon at Cleveland Clinic discussed the goals of the AES thalamic neuromodulation special interest group and the major clinical and research priorities shaping the future of neuromodulation for drug resistant epilepsy.

AES Poster Showcases Feasibility of Mobile App to Track Daily Self-Reporting Epilepsy Outcomes Isabella Ciccone, MPH

A new study presented at AES 2025 reported that a cognitive-behavioral intervention via mobile application for patients with epilepsy can reliably capture daily self-reported outcomes.

Survey identifies Fever-Related Seizure Reduction as Key Feature of CDKL5 Deficiency Disorder Louie Pasculli

A recent survey reveals fever significantly reduces seizure frequency in CDKL5 Deficiency Disorder, highlighting potential therapeutic strategies for patients.

Long-Term Expanded Access Program Data Support Phase 3 Development of Bexicaserin in Developmental Epileptic Encephalopathies Marco Meglio

New findings reveal bexicaserin significantly reduces seizure frequency in patients with developmental and epileptic encephalopathies, supporting its advancement to phase 3 trials.

FDA Action Update, November 2025: Approvals, Clearance, and Boxed Warning Isabella Ciccone, MPH

Catch up on any of the neurology news headlines you may have missed in November 2025, compiled into 1 place by the NeurologyLive® team.

Patient Attitudes Key to Effective Hyperuricemia Self-Management

Patient Attitudes Key to Effective Hyperuricemia Self-Management

Todays Updates

FDA Accepts NDA for Low-Sodium Oxybate TRN-257 in Narcolepsy and Idiopathic Hypersomnia Isabella Ciccone, MPH

TRN-257, a treatment in development for adults with narcolepsy and idiopathic hypersomnia, is designed to reduce daily sodium exposure relative to existing higher-sodium therapies.

NeuroVoices: Richard Rammo, MD, on How Thalamic Neuromodulation is Evolving for Drug Resistant Epilepsy Marco Meglio, Richard Rammo, MD

The neurosurgeon at Cleveland Clinic discussed the goals of the AES thalamic neuromodulation special interest group and the major clinical and research priorities shaping the future of neuromodulation for drug resistant epilepsy.

AES Poster Showcases Feasibility of Mobile App to Track Daily Self-Reporting Epilepsy Outcomes Isabella Ciccone, MPH

A new study presented at AES 2025 reported that a cognitive-behavioral intervention via mobile application for patients with epilepsy can reliably capture daily self-reported outcomes.

Survey identifies Fever-Related Seizure Reduction as Key Feature of CDKL5 Deficiency Disorder Louie Pasculli

A recent survey reveals fever significantly reduces seizure frequency in CDKL5 Deficiency Disorder, highlighting potential therapeutic strategies for patients.

Long-Term Expanded Access Program Data Support Phase 3 Development of Bexicaserin in Developmental Epileptic Encephalopathies Marco Meglio

New findings reveal bexicaserin significantly reduces seizure frequency in patients with developmental and epileptic encephalopathies, supporting its advancement to phase 3 trials.

FDA Action Update, November 2025: Approvals, Clearance, and Boxed Warning Isabella Ciccone, MPH

Catch up on any of the neurology news headlines you may have missed in November 2025, compiled into 1 place by the NeurologyLive® team.

Patient Attitudes Key to Effective Hyperuricemia Self-Management

Patient Attitudes Key to Effective Hyperuricemia Self-Management

Latest News

A 67-year-old man visited the doctor for a cyst-like lesion that developed on his face 3 months prior.

Positive signs in phase II test

Dazukibart targets specific molecular pathology of chronic systemic autoimmune disease

Patients' C-reactive protein levels also reflect significantly higher BMI and disease severity

Don't forget the power of a strong doctor-patient relationship

A 62-year-old woman visited her doctor about thick, crumbling, discolored toenails that developed over many months. Can you diagnose the patient?

News All Time

Novel Drug for Chronic Inducible Urticaria Delivers in Mid-Stage Trial

Impressive responses with barzolvolimab in cold urticaria, symptomatic dermographism

Dupilumab Proves Effective in Chronic Spontaneous Urticaria

Significant reduction in hives and itch in antihistamine-resistant patients

50 Years After City Halted Prison Medical Testing, Families Seek Reparations

"No amount of money can replace what was done to me," said one former prisoner

Make the Diagnosis: She Feels Fine, But Why Do Her Fingers Look Like This?

A 38-year-old woman visited her doctor about itchy, raised spots that developed on her fingers 5 days prior. Can you diagnose the patient?

A Look at Kamala Harris' Medical History

Veep in "excellent health," doctor says, with history that includes seasonal allergies, urticaria

Selective Role for Single-Agent Ipilimumab After Anti-PD-1 Failure in Melanoma

Two-year survival in second line for patients with BRAF/NRAS wild-type tumors

Acne Treatments Taken Right Off the Shelf Had High Levels of Benzene

Study findings suggest cold storage may prevent breakdown into carcinogen

Make the Diagnosis: It’s Ugly, and It Hurts. What the Heck Is It?

A 29-year-old woman visited the doctor for a painful rash that developed on her arm 1 day after working on a landscaping project that involved pulling weeds under intense sunlight. Can you diagnose the patient?

Hitting Psoriatic Arthritis Early With Apremilast Helps Some Patients, Trial Finds

But only a minority achieved minimal disease activity within 16 weeks

Lebrikizumab Wins FDA Approval for Eczema

38% of patients treated with IL-13 blocker achieved clear or almost-clear skin at 16 weeks

Higher Steroid Dose for ICI Toxicity Harms Cancer Survival, Analysis Suggests

More data for discussion of controversial association between steroids, immunotherapy

Stopping JAK Inhibitor for Severe Alopecia Areata Led to Hair Loss

Long-term maintenance therapy is necessary, researchers caution

IL-31 Drug for Itchy Nodular Skin Disease Gets Thumbs Up From FDA

Nemolizumab significantly improved itch, nodules, and sleep disturbance at 16 weeks

IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL

New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients

Psoriasis Control Maintained Long Term With Extended Dosing Interval of Guselkumab

More than 90% of patients met response criteria at 68 weeks with 8- or 16-week dosing

Common Antibiotics Linked With Serious Skin Reactions in Older Adults

Sulfonamides and cephalosporins the worst offenders, study finds

Recommended News For You

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.

We Don't Always Know What's 'Best' for Our Patients

Why preventive mastectomy isn't offered to everyone at risk

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

Taking Charge of Your Cancer Journey.

FDA Approves Hemophilia B Second Gene Therapy.

Recommended Articles For You

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium 

Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights 

CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review 

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

3D virtual staining technology enables non-invasive observation of cancer tissue

2.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

3.

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

4.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

5.

Year in Review: Non-Small Cell Lung Cancer

1.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

2.

Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed

3.

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances

4.

A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis

5.

Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Should We Use DARA Up Front As First-Line Therapy in MM?

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

5.

Updates on Standard V/S High Risk Myeloma Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot